Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers

ClinicalTrials.gov ID: NCT01935960

Public ClinicalTrials.gov record NCT01935960. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 26, 2026, 9:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30

Study identification

NCT ID: NCT01935960
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: National Cancer Institute (NCI); NIH
Enrollment: 40 participants

Conditions and interventions

Conditions

Healthy Subject

Interventions

Laboratory Biomarker Analysis Other
Pharmacological Study Other
Placebo Other
Retinoid 9cUAB30 Drug

Other · Drug

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 31, 2013
Primary completion: Sep 30, 2016
Completion: Not listed
Last update posted: Dec 22, 2016

Started 2013

United States locations

U.S. sites: 3
U.S. states: 3
U.S. cities: 3

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham Cancer Center	Birmingham	Alabama	35233	—
University of Iowa/Holden Comprehensive Cancer Center	Iowa City	Iowa	52242	—
University of Wisconsin Hospital and Clinics	Madison	Wisconsin	53792	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01935960, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 22, 2016 · Synced Jun 26, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01935960 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →